Limited utility of the cardiomyopathy blood panel in identifying aetiology in dilated cardiomyopathy cases has been noted.
Only a small proportion of idiopathic dilated cardiomyopathy cases were linked to specific aetiologies through blood tests.
Assessment focusing on aetiological relevance reveals a continued challenge in managing dilated cardiomyopathy effectively.
Future research may highlight the need for alternative diagnostic approaches in idiopathic dilated cardiomyopathy cases.
Abstract
Despite thorough clinical assessment, DCM remains idiopathic in at least half of cases. Adding an extensive blood panel identifies a specific aetiology in a small proportion of cases.